Intercept Pharmaceuticals, Inc.

NJ · United States · Reporting entity ID 100000151645

Total reported 2019–2025

$116.4M

#84 of 2,960 reporting companies — 0.1% of all reported industry payments

$18.4M in general payments across 76,009 records, plus $97.3M in research funding across 18,027 records.

How it breaks down

General payments $18,373,120

Research funding $97,259,943

Ownership & investment $767,060

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.